- Home
- / Strides Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Strides Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₹1.5 K
2024-10-29
Market Capitalization
₹143.2 B
2024-10-29
Revenue
₹43.9 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.0B | 29.4B | 28.9B | 32.5B | 30.2B | 36.1B | 38.9B | 43.9B |
| Cost of goods sold | 14.2B | 15.0B | 11.8B | 14.1B | 15.8B | 17.0B | 17.3B | 20.6B |
| Gross profit | 27.8B | 15.2B | 18.2B | 19.1B | 14.9B | 19.9B | 23.8B | 24.7B |
| Gross profit margin, % | 51.7% | 63.0% | 58.9% | 49.2% | 55.1% | 61.2% | 56.3% | |
| Operating expense total | 16.9B | 10.4B | 12.5B | 12.6B | 15.0B | 16.0B | 15.7B | 17.0B |
| Depreciation and amortization | 2.1B | 1.8B | 1.9B | 2.1B | 2.3B | 2.4B | 2.2B | 1.9B |
| EBITDA | 10.8B | 4.4B | 4.6B | 5.6B | (1.2B) | 1.0B | 6.3B | 7.7B |
| EBITDA margin, % | 14.8% | 15.9% | 17.2% | -4.1% | 2.8% | 16.2% | 17.6% | |
| EBIT | 8.3B | 2.6B | 1.9B | 4.0B | (5.9B) | (1.5B) | 2.3B | 6.5B |
| EBIT margin, % | 8.7% | 6.5% | 12.4% | -19.6% | -4.2% | 5.8% | 14.8% | |
| Interest income | 90.1M | 222.8M | 368.9M | 353.0M | 1.1B | 745.1M | 296.4M | 453.7M |
| Interest expense | 2.0B | 2.1B | 1.6B | 1.5B | 1.8B | 2.6B | 3.1B | 2.5B |
| Pre tax profit | 7.1B | 3.4B | 485.1M | 2.9B | (6.5B) | (2.7B) | (627.2M) | 36.8B |
| Income tax expense | 214.1M | 144.9M | 179.1M | 316.5M | (1.8B) | (553.0M) | 315.9M | 775.2M |
| Net Income | 6.8B | 3.3B | 306.0M | 2.6B | (4.7B) | (2.1B) | (943.1M) | 36.0B |